Published in Prostate on January 01, 1987
The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines. Cancer Chemother Pharmacol (2009) 0.93
Therapy of murine squamous cell carcinomas with 2-difluoromethylornithine. J Carcinog (2004) 0.76
Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet (1992) 3.40
Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus (2002) 1.98
Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study. J Urol (1993) 1.46
Neurologic manifestations of cumulative trauma disorder. Am J Orthop (Belle Mead NJ) (1996) 1.38
Genetic linkage of Werner's syndrome to five markers on chromosome 8. Nature (1992) 1.37
Letter: Levulinic esters. An alcohol protecting group applicable to some nucleosides. J Am Chem Soc (1975) 1.31
Changes in the blood level and affinity to concanavalin A of rat plasma glycoproteins during acute inflammation and hepatoma growth. Biochem J (1982) 1.23
Primary renal sarcoma in adults. A natural history and management study by the American Cancer Society, Illinois Division. Cancer (1993) 1.12
Prolyl tripeptidyl peptidase from Porphyromonas gingivalis. A novel enzyme with possible pathological implications for the development of periodontitis. J Biol Chem (1999) 1.09
Degradation of elastin by a cysteine proteinase from Staphylococcus aureus. J Biol Chem (1988) 1.08
Molecular cloning and biochemical characterisation of proteases from Staphylococcus epidermidis. Biol Chem (2001) 1.07
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
On the hormonal modulation of acute-phase plasma protein synthesis in perfused rat liver. Acta Biochim Pol (1974) 1.01
Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab Invest (1996) 0.97
Proteolytic inactivation of alpha-1-anti-chymotrypsin. Sites of cleavage and generation of chemotactic activity. J Biol Chem (1991) 0.97
Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein. Eur J Biochem (1997) 0.96
The occurrence of common inhibitors of trypsin and of leucocyte neutral proteinase in human serum. Biochim Biophys Acta (1972) 0.95
Inhibition of the liver and plasma protein acute-phase response in mice by D-galactosamine. Br J Exp Pathol (1976) 0.95
Alpha-1-acute phase globulin in the blood of tunicamycin-injected rats. Isolation of the non-glycosylated form, its inhibitory properties and synthesis in liver slices. Folia Histochem Cytobiol (1986) 0.94
Prostate cancer in Illinois. IMJ Ill Med J (1984) 0.93
In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells. Anticancer Res (2009) 0.92
Cochlear action potentials in experimentally induced hypothyroidism in guinea pigs. Acta Otolaryngol Suppl (1975) 0.91
Changes in radical prostatectomy and radiation therapy rates for African Americans and whites. J Natl Med Assoc (2000) 0.90
An elastase inhibitor from equine leukocyte cytosol belongs to the serpin superfamily. Further characterization and amino acid sequence of the reactive center. J Biol Chem (1988) 0.89
Hormonal therapy and alteration of lymphocyte proliferation. J Lab Clin Med (1976) 0.89
Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate. Cancer Res (1978) 0.89
Periarticular inflammation, bilateral hilar adenopathy and a sarcoid reaction. Arthritis Rheum (1970) 0.89
Successful streptokinase therapy for catheter-induced subclavian vein thrombosis. Arch Intern Med (1980) 0.87
Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol (1985) 0.87
Isolation and some molecular parameters of elastase-like normal proteinases from horse blood leucocytes. Biochem J (1976) 0.87
A new therapeutic approach to the fetus with congenital complete heart block: preemptive, targeted therapy with dexamethasone. Obstet Gynecol (1998) 0.87
A genetic analysis of the Werner syndrome region on human chromosome 8p. Genomics (1993) 0.87
Renal cell carcinoma: the size variable. J Surg Oncol (1993) 0.86
The significance of L forms in human renal disease. J Urol (1972) 0.86
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor. Eur J Cancer (1977) 0.85
Neurobiology of receptor-mediated lysophospholipid signaling. From the first lysophospholipid receptor to roles in nervous system function and development. Ann N Y Acad Sci (2000) 0.85
Antimicrobial peptides derived from heme-containing proteins: hemocidins. Antonie Van Leeuwenhoek (2000) 0.84
Renal medullary carcinoma in patients with sickle cell trait. Urology (1998) 0.84
Septic encephalopathy. Evidence for altered phenylalanine metabolism and comparison with hepatic encephalopathy. Arch Intern Med (1990) 0.84
The effect of D-galactosamine on plasma protein synthesis by the perfused rat liver from turpentine-stimulated donors. Br J Exp Pathol (1978) 0.84
Regulation of vitamin K-dependent carboxylation. J Biol Chem (1980) 0.84
Molecular cloning and expression of an intracellular serpin: an elastase inhibitor from horse leucocytes. Biochem J (1993) 0.83
Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins. Infect Immun (1996) 0.83
Solitary renal calix. JAMA (1978) 0.83
Gross hematuria and abdominal aortic aneurysm. J Urol (1967) 0.82
Stimulation of vitamin K-dependent carboxylation by pyridoxal-5'-phosphate. Biochem Biophys Res Commun (1979) 0.82
Immunosuppression of cell- and serum-medicated tumour-associated immunity in prostatic cancer by human seminal plasma. Eur J Cancer (1980) 0.82
An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer. J Surg Oncol (1998) 0.82
Adjuvant immunotherapy (BCG) in stage D prostate cancer. Am J Clin Oncol (1982) 0.82
Pleural fluid lactic acid dehydrogenase activity and protein content. Value in diagnosis. Arch Intern Med (1969) 0.82
Malacoplakia of the prostate. South Med J (1977) 0.81
Substrate specificity and modifications of the active centre of elastase-like neutral proteinases from horse blood leucocytes. Biochem J (1976) 0.81
Value of tumor size in predicting survival from renal cell carcinoma among tumors, nodes and metastases stage 1 and stage 2 patients. J Urol (1994) 0.81
The proliferative response of hela cells to 2-deoxy-D-glucose under hypoxic or anoxic conditions: an analogue for studying some properties of in vivo solid cancers. Anticancer Res (2007) 0.81
The intracellular serpin family. Acta Biochim Pol (1996) 0.81
An evaluation of five tests to diagnose prostate cancer. Prog Clin Biol Res (1987) 0.81
Comparison of antiproteolytic activities of alpha-1-proteinase inhibitors from the plasma of some mammalian species. Comp Biochem Physiol B (1986) 0.81
Report of 337 patients with renal cell carcinoma emphasizing 110 with stage IV disease and review of the literature. J Surg Oncol (1997) 0.81
Bone scan as a stratification variable in advanced prostate cancer. Cancer (1991) 0.80
A polyvalent proteinase inhibitor from horse-blood-leucocyte cytosol. Isolation, purification and some molecular parameters. Eur J Biochem (1977) 0.80
Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancer. Eur Urol (1980) 0.80
Elastinolytic activity of horse leukocyte proteinases. Comparison with elastases from human leukocytes and porcine pancreas. Folia Histochem Cytobiol (1986) 0.80
Carcinoembryonic antigen in the diagnosis of prostate carcinoma. Oncology (1974) 0.80
An immunohistologic characterization of human prostatic atypical hyperplasia. Urol Res (1990) 0.79
Percutaneous cryoablation of the prostate: preliminary results after 95 procedures. J Urol (1995) 0.79
A qualitative analysis of acidic proteins associated with regressing, growing, or dividing rat ventral prostate cells. Prostate (1983) 0.79
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration. Urol Int (1976) 0.79
Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model. Methods Find Exp Clin Pharmacol (1998) 0.79
Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancer. Clin Exp Immunol (1979) 0.79
Application of immunohistologic staining to develop a malignant index to aid in distinguishing benign from malignant prostatic tissue. Prostate (1989) 0.79
Comparative properties of human alpha-1-proteinase inhibitor glycosylation variants. FEBS Lett (1990) 0.79
Normoxic or hypoxic CD44/CD41 a₂ B₁ integrin-positive prostate PC3 cell side fractions and cancer stem cells. Med Oncol (2013) 0.79
[Neutral protease from horse blood granulocytes (author's transl)]. Przegl Lek (1974) 0.79
Immunologic aspects of malignancy. II. Host immunocompetence and relationship to the clinical stage in patients with prostatic cancer. Allergol Immunopathol (Madr) (1976) 0.78
On the contents and importance of methionine in rabbit alpha 1-proteinase inhibitors F and S. Folia Biol (Krakow) (1985) 0.78
Significance of serum aminograms in diagnosis and prognosis of liver diseases. J Clin Gastroenterol (1984) 0.78
The effect of androgen deprivation on malignant and benign prostate tissue. Med Oncol (1998) 0.78
Effect of cadmium on acute-phase protein synthesis in perfused rat liver. Toxicol Appl Pharmacol (1978) 0.78
Subclinical renal response to streptococcal infection. N Engl J Med (1966) 0.78
Are cancer stem cells concentrated in more alkaline hypoxic regions of tumors? Med Hypotheses (2009) 0.78
Effect of cyclophosphamide on leukocytic subset distributions in rats carrying the Dunning R3327-MAT-LyLu prostatic adenocarcinoma. Prostate (1987) 0.78
Cell-mediated immunity in prostatic cancer. Clin Oncol (1980) 0.78
Hamster antithrombin III: purification, characterization and acute phase response. Comp Biochem Physiol B Biochem Mol Biol (1996) 0.78
The effect of normoxia and hypoxia on a prostate (PC-3) CD44/CD41 cell side fraction. Anticancer Res (2011) 0.78
Tumor-associated immunity in prostatic cancer as evaluated by tube antigen-induced leukocyte adherence inhibition: reactivity and specificity of responsiveness, and relationship to stage, grade and therapy. J Reticuloendothel Soc (1979) 0.78
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of antitumour cell-mediated immunity. Eur J Cancer (1979) 0.78
Videotape tic counts in the assessment of Tourette's syndrome: stability, reliability, and validity. J Am Acad Child Adolesc Psychiatry (1994) 0.78
Relationship of arachidonic acid metabolism to indomethacin-sensitive immunoregulatory function and lymphocyte PGE sensitivity in peripheral blood mononuclear cells of disseminated solid tumor cancer patients. J Immunopharmacol (1984) 0.78
Isolation of urinary proteose (an alpha-1-glycoprotein). Biochem Biophys Res Commun (1964) 0.78
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer. J Urol (1983) 0.78
To what extent are the "sets" of biologic properties expressed by hypoxic cancer cells and by cancer "stem" cells equivalent, intersecting, disjoint or complementary? Some implications for the design of cancer therapies. Med Hypotheses (2006) 0.77
Plasma proteinase inhibitors in Morris hepatoma-bearing rats: changes in the blood level and synthesis in tissue slices. Int J Biochem (1985) 0.77